Background: Up to now, a transdermal therapeutic system (TTS) of fentanyl has been
applied to cancer patients on opioid analgesics previously treated with mild opioids or …

There is emerging data supporting the use of TTS‐F (transdermal therapeutic system‐
fentanyl) in opioid naive patients. Our study examines the safety and efficacy of TTS‐F in the …

We have performed a prospective evaluation of the efficacy, safety and convenience of the
transdermal therapeutic system–fentanyl (TTS‐F) in Turkish cancer patients when it was …

Objective: To determine the safety and efficacy of transdermal fentanyl for pain relief in
cancer patients and to compare the effects on patients according to whether they had …

Objective: The aim of this study was to evaluate the effect and tolerability of low doses of
transdermal (TD) fentanyl patches in opioid-naive patients with cancer pain. Methods: This …

Two studies including a total of 70 patients evaluated the efficacy and side effects of a
combination of initial patient-controlled analgesia (PCA) for dose finding with transdermal …

The aim of this observational study was to examine pain management outcomes and quality
of life (QoL) measures in cancer patients with intolerable or chronic severe pain transferring …

Background [corrected] The aim of the study was to evaluate prospectively the analgesic
efficacy, toxicity and acceptability of the transdermal fentanyl therapeutic system (TTS-F) in …

To treat cancer pain, physicians often decide to jump directly from step 1 of the World Health
Organization (WHO) analgesic ladder to step 3. The use of transdermal fentanyl in patients …

Goals of the work: This open compassionate-use prospective registration study evaluated
the tolerability, ease of use and applied doses of transdermal (TTS) fentanyl in adult patients …